APONTIS PHARMA AGAPONTIS PHARMA AGAPONTIS PHARMA AG

APONTIS PHARMA AG

No trades
See on Supercharts

APPH fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. Its single pill products focus on cardiovascular diseases such as hypertension, hyperlipidemia, and secondary prevention. The company was founded on March 19, 2018 and is headquartered in Monheim am Rhein, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

APPH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company